The Novartis Prizes for Immunology are awarded to scientists who made groundbreaking contributions to both basic- and clinical immunology. The Prizes are awarded during a ceremony at the triennial International Congress of Immunology, which is the most important global event in the field of immunology.
In 1990 Sandoz established the Sandoz Prize for Immunology, which was expanded to its present format in 1992. Novartis was created in 1996 through a merger of Sandoz and Ciba. Since then the Prizes have been known as the Novartis Prizes for Immunology, one for Basic – and one for Clinical Immunology, each endowed with 100,000 SFr which can be shared by up to three scientists. One fifth of each prize is awarded in personal recognition of exceptional individual achievements, while the remainder is intended to support the prize winner’s research. The prizes were established both to honor outstanding research in the most challenging areas of immunology-based science and to increase interactions between scientists in academia and industry. In addition they reflect Novartis’ commitment to support research in immunology as a key area for medical progress in treating, or even curing, immunological diseases with a high unmet medical need.
The Prizes are awarded for
Outstanding achievements in the understanding of immunological processes in health and disease and major discoveries resulting in novel treatments for immunological diseases such as autoimmune- and inflammatory diseases, transplantation, infectious diseases, immunotherapy of cancer, allergic -and dermatological diseases and asthma.